Oncology Pharma Stock Forecast

Buy candidate since Jul 31, 2026

The Oncology Pharma stock price gained 27.27% on the last trading day (Friday, 31st Jul 2026), rising from $0.0550 to $0.0700. During the last trading day the stock fluctuated 40.00% from a day low at $0.0500 to a day high of $0.0700. The price has risen in 5 of the last 10 days and is up by 39.72% over the past 2 weeks. Volume fell on the last day by -149 shares and in total, 321 shares were bought and sold for approximately $22.47 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $0.0693, a level that may pose a second chance to hit a runner. According to fan-theory $0.102 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

ONPH Signals & Forecast

The Oncology Pharma stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.0565 and $0.0566. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 39.72%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Oncology Pharma stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0616 and $0.0610. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Oncology Pharma finds support just below today's level at $0.0616. If this is broken, then the next support from accumulated volume will be at $0.0610 and $0.0600.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0200 between high and low, or 40.00%. For the last week the stock has had daily average volatility of 28.09%.

Our recommended stop-loss: $0.0677 (-3.26%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (ONPH) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Oncology Pharma Inc. to open at $0.0633, and during the day (based on 14 day Average True Range), to move between $0.0621 and $0.0779, which gives a possible trading interval of +/-$0.0158 (+/-25.49%) up or down from last closing price. If Oncology Pharma Inc. takes out the full calculated possible swing range there will be an estimated 25.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0702 (0.29%) than the support at $0.0616 (12.00%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Oncology Pharma Inc. stock A Buy?

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 4.115 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $0.0633 ( 9.52%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk